Efficacy and safety of saxagliptin in combination with metformin as initial therapy in Chinese patients with type 2 diabetes: Results from the START study, a multicentre, randomized, double‐blind, active‐controlled, phase 3 trial

    loading  Checking for direct PDF access through Ovid


Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles